# A Randomized, Open-Label, Multi-Center Study of Vestibular Migraine Prevention: Rimegepant Versus Flunarizine Non-inferiority Study

> **NCT07751497** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Second Affiliated Hospital, Zhejiang University, School of Medicine** · enrollment: 400 (estimated)

## Conditions studied

- Vestibular Migraine

## Interventions

- **DRUG:** Rimegepant
- **DRUG:** Flunarizine

## Key facts

- **NCT ID:** NCT07751497
- **Lead sponsor:** Second Affiliated Hospital, Zhejiang University, School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-12-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2029-04-01
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2026-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07751497

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07751497, "A Randomized, Open-Label, Multi-Center Study of Vestibular Migraine Prevention: Rimegepant Versus Flunarizine Non-inferiority Study". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07751497. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*